跳到主要內容

Flowers Kirsten 的 Form 4/A 修正申報

修正

Comera Life Sciences Holdings, Inc.CMRA,2023/2/14 申報

申報編號
0001062993-23-003492
申報時間
2023/2/14 17:27 ET
交易日
2023/1/4
申報延遲
41 天
10b5-1 計畫
表單沒有這欄(2023 年以前)
原始申報日
2023/1/6

這份申報列了 1 筆非衍生性交易、1 筆衍生性交易。公開市場買進合計 $1.66 萬。交易後 41 天申報。

這份修正申報取代了 0001062993-23-000607(2023/1/6 申報)。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Flowers KirstenCIK 0001797209董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/1/4Common StockP買進取得+13,513$1.23F2+$16,620.9922,199直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2023/1/4Common StockP買進取得+27,026$0.25+$3,378.2513,513直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

This Form 4/A is being filed to (i) correct a typographical error in the transaction code disclosed in Column 3 in Table I and Column 4 in Table II in the original Form 4, filed on January 6, 2023, from "A" to "P" and (ii) correct a typographical error in the power-of-attorney of the reporting person.

F2

The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 13,513 units (the "Units") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the "Common Stock"), and one warrant (the "Warrants") to purchase two shares of Common Stock (the "Warrant Shares") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules.

表 I 有 1 筆交易的價格引用這則附註。

F3

The exercisability of the Warrants is subject to a 4.99% beneficial ownership limitation.

備註

Exhibit 24 Power of Attorney filed herewith.

看 SEC EDGAR 上的完整原文 (在新分頁開啟)